Project Details
Description
Development of a treatment for durable remission of HIV using transposon engineered CAR-T and NK cells
| Status | Finished |
|---|---|
| Effective start/end date | 12/7/22 → 11/30/23 |
Funding
- MARPAM PHARMA LLC
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.